about fansalaran
FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.
Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion
Biogen said on Friday it has gained global rights...
Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation
Daewoong Pharmaceutical said on October 17 that it met...
CINV Drugs Market to Reach USD 2.49 Bn by 2032 | Key Trends, Pipeline Therapies & Leading Players (2025–2032)
Global CINV Existing and Pipeline Drugs Market, valued at...
Novo Nordisk chair and independent directors to exit in strategy dispute
The chair of Wegovy maker Novo Nordisk and six...
Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG
Medical diagnostics firm Hologic has agreed to be acquired...
Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion
Biogen said on Friday it has gained global rights...
Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation
Daewoong Pharmaceutical said on October 17 that it met...
CINV Drugs Market to Reach USD 2.49 Bn by 2032 | Key Trends, Pipeline Therapies & Leading Players (2025–2032)
Global CINV Existing and Pipeline Drugs Market, valued at...
Novo Nordisk chair and independent directors to exit in strategy dispute
The chair of Wegovy maker Novo Nordisk and six...
Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG
Medical diagnostics firm Hologic has agreed to be acquired...
Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion
Biogen said on Friday it has gained global rights...
Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation
Daewoong Pharmaceutical said on October 17 that it met...
CINV Drugs Market to Reach USD 2.49 Bn by 2032 | Key Trends, Pipeline Therapies & Leading Players (2025–2032)
Global CINV Existing and Pipeline Drugs Market, valued at...
Novo Nordisk chair and independent directors to exit in strategy dispute
The chair of Wegovy maker Novo Nordisk and six...
Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG
Medical diagnostics firm Hologic has agreed to be acquired...
Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion
Biogen said on Friday it has gained global rights...
Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation
Daewoong Pharmaceutical said on October 17 that it met...
CINV Drugs Market to Reach USD 2.49 Bn by 2032 | Key Trends, Pipeline Therapies & Leading Players (2025–2032)
Global CINV Existing and Pipeline Drugs Market, valued at...
Novo Nordisk chair and independent directors to exit in strategy dispute
The chair of Wegovy maker Novo Nordisk and six...
Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG
Medical diagnostics firm Hologic has agreed to be acquired...
"Fansalaran showcases the latest news and the top pharmaceutical brands in the country. With Fansalaran, you can be seen globally."
Headlines
Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion
Biogen said on Friday it has gained global rights...
Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation
Daewoong Pharmaceutical said on October 17 that it met...
CINV Drugs Market to Reach USD 2.49 Bn by 2032 | Key Trends, Pipeline Therapies & Leading Players (2025–2032)
Global CINV Existing and Pipeline Drugs Market, valued at...
Novo Nordisk chair and independent directors to exit in strategy dispute
The chair of Wegovy maker Novo Nordisk and six...
Fansalaran
Get important news delivered directly to your inbox and stay connected!